One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. - Zheng, Amy; Murray, Eleanor J; Brennan, Alana T; Greener, Ross; Kileel, Emma M; Bor, Jacob; Venter, Willem D F; Pisa, Pedro T; Fox, Matthew P; Maskew, Mhairi (Open Forum Infectious Diseases, 2026)